Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Aristotle Small Cap Equity Fund. This analysis is provided for institutional research purposes only and is not investment advice.
"The Aristotle Small Cap Equity Fund posted a 1.96% return in Q4 2025, slightly lagging its benchmark due to tactical healthcare underweights. The manager remains constructive on the asset class, leveraging a bottom-up quality approach to exploit historically cheap small-cap valuations."
For the fourth quarter of 2025, the Aristotle Small Cap Equity Fund (Class I-2) generated a total return of 1.96%, underperforming the 2.19% return of the Russell 2000 Index. Underperformance was driven by allocation headwinds, specifically an underweight to the high-performing healthcare sector, while security selection in industrials and information technology served as a positive offset. The fund engaged in active capital redeployment, completing nine new acquisitions (including AptarGroup, Atlantic Union Bankshares, and LKQ Corporation) and liquidating nine positions due to corporate acquisitions or deteriorating fundamentals. The manager maintains a constructive outlook on U.S. small-cap equities, citing multi-decade low valuations relative to large-caps and structural macro tailwinds like reshoring and deregulation.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
High-conviction positioning: The Aristotle Small Cap Equity Fund posted a 1.96% return in Q4 2025, slightly lagging its benchmark due to tactical healthcare underweights. The manager remains constructive on th...
Growth Outlook
Market outlook remains high conviction: The Aristotle Small Cap Equity Fund posted a 1.96% return in Q4 2025, slightly lagging its benchmark due to tactical healthcare underweights. The manager remains constructive on th...
Risk Appetite
Risk appetite posture is moderate conviction: The Aristotle Small Cap Equity Fund posted a 1.96% return in Q4 2025, slightly lagging its benchmark due to tactical healthcare underweights. The manager remains constructive on th...
Capital Deployment
Manager actively deployed capital into high-conviction opportunities. The Aristotle Small Cap Equity Fund posted a 1.96% return in Q4 2025, slightly lagging its benchmark due to tactical healthcare underweights. The manager remains constructive on th...
Forward Guidance
Forward guidance signal: The Aristotle Small Cap Equity Fund posted a 1.96% return in Q4 2025, slightly lagging its benchmark due to tactical healthcare underweights. The manager remains constructive on th...
Language Signal
Tone analysis indicates above average conviction language: The Aristotle Small Cap Equity Fund posted a 1.96% return in Q4 2025, slightly lagging its benchmark due to tactical healthcare underweights. The manager remains constructive on th...
Perceived Risk
Perceived risk level is evaluated as moderate conviction. The Aristotle Small Cap Equity Fund posted a 1.96% return in Q4 2025, slightly lagging its benchmark due to tactical healthcare underweights. The manager remains constructive on th...
Opportunity Density
Opportunity density index indicates above average conviction actionable entry points. The Aristotle Small Cap Equity Fund posted a 1.96% return in Q4 2025, slightly lagging its benchmark due to tactical healthcare underweights. The manager remains constructive on th...
Time Horizon
Investment time horizon reflects a high conviction orientation. The Aristotle Small Cap Equity Fund posted a 1.96% return in Q4 2025, slightly lagging its benchmark due to tactical healthcare underweights. The manager remains constructive on th...
